| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 3.15e-11 | 28 | 18 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.03e-10 | 35 | 18 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 5.42e-10 | 48 | 18 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.03e-10 | 49 | 18 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.26e-08 | 107 | 18 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.96e-07 | 153 | 18 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.22e-07 | 66 | 18 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 3.85e-07 | 69 | 18 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 9.63e-07 | 211 | 18 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.78e-06 | 239 | 18 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.40e-06 | 254 | 18 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.43e-06 | 288 | 18 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | steroid binding | 5.35e-06 | 133 | 18 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 2.12e-05 | 398 | 18 | 5 | GO:0046982 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 5.33e-04 | 435 | 18 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 6.15e-04 | 815 | 18 | 5 | GO:0042803 | |
| GeneOntologyMolecularFunction | lipid binding | 1.47e-03 | 988 | 18 | 5 | GO:0008289 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 1.72e-03 | 596 | 18 | 4 | GO:0140678 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 3.51e-03 | 1205 | 18 | 5 | GO:0046983 | |
| GeneOntologyMolecularFunction | protein kinase binding | 6.80e-03 | 873 | 18 | 4 | GO:0019901 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 7.04e-03 | 1418 | 18 | 5 | GO:0030234 | |
| GeneOntologyMolecularFunction | kinase binding | 9.77e-03 | 969 | 18 | 4 | GO:0019900 | |
| GeneOntologyMolecularFunction | structural constituent of ribosome | 1.16e-02 | 183 | 18 | 2 | GO:0003735 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.03e-12 | 5 | 18 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.56e-12 | 21 | 18 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 6.08e-12 | 6 | 18 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 6.08e-12 | 6 | 18 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 6.08e-12 | 6 | 18 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.79e-11 | 26 | 18 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.79e-11 | 26 | 18 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 8.50e-11 | 10 | 18 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 8.50e-11 | 10 | 18 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.89e-10 | 13 | 18 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.41e-09 | 21 | 18 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 5.57e-09 | 5 | 18 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.85e-08 | 34 | 18 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.07e-07 | 52 | 18 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.11e-07 | 141 | 18 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.22e-07 | 12 | 18 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.01e-07 | 67 | 18 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.06e-06 | 222 | 18 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.18e-06 | 94 | 18 | 4 | GO:0042440 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.40e-06 | 40 | 18 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | liver development | 2.45e-05 | 202 | 18 | 4 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 2.60e-05 | 205 | 18 | 4 | GO:0061008 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.05e-05 | 89 | 18 | 3 | GO:0001523 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 6.82e-05 | 525 | 18 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 7.12e-05 | 94 | 18 | 3 | GO:0016101 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 9.50e-05 | 286 | 18 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 9.89e-05 | 105 | 18 | 3 | GO:0006721 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 2.36e-04 | 684 | 18 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.52e-04 | 144 | 18 | 3 | GO:0006720 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 2.72e-04 | 376 | 18 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 2.88e-04 | 382 | 18 | 4 | GO:0016042 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 3.22e-04 | 731 | 18 | 5 | GO:0032787 | |
| GeneOntologyBiologicalProcess | replication fork processing | 9.29e-04 | 52 | 18 | 2 | GO:0031297 | |
| GeneOntologyBiologicalProcess | gland development | 1.20e-03 | 558 | 18 | 4 | GO:0048732 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 1.24e-03 | 60 | 18 | 2 | GO:0045005 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 1.56e-03 | 1035 | 18 | 5 | GO:0019752 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 1.72e-03 | 1058 | 18 | 5 | GO:0043436 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 1.76e-03 | 1064 | 18 | 5 | GO:0006082 | |
| GeneOntologyBiologicalProcess | DNA damage response, signal transduction by p53 class mediator | 2.08e-03 | 78 | 18 | 2 | GO:0030330 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 5.73e-03 | 131 | 18 | 2 | GO:0032526 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 5.99e-03 | 134 | 18 | 2 | GO:0014910 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 6.70e-03 | 142 | 18 | 2 | GO:0034728 | |
| GeneOntologyCellularComponent | cytosolic large ribosomal subunit | 1.16e-03 | 59 | 18 | 2 | GO:0022625 | |
| GeneOntologyCellularComponent | heterochromatin | 3.36e-03 | 101 | 18 | 2 | GO:0000792 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 3.91e-03 | 1293 | 18 | 5 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 3.99e-03 | 1299 | 18 | 5 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 4.37e-03 | 1327 | 18 | 5 | GO:0042175 | |
| GeneOntologyCellularComponent | large ribosomal subunit | 4.56e-03 | 118 | 18 | 2 | GO:0015934 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 5.02e-03 | 124 | 18 | 2 | GO:0022626 | |
| GeneOntologyCellularComponent | chromatin | 6.95e-03 | 1480 | 18 | 5 | GO:0000785 | |
| GeneOntologyCellularComponent | ribosomal subunit | 1.19e-02 | 194 | 18 | 2 | GO:0044391 | |
| Domain | UDPGT | 9.13e-12 | 21 | 18 | 5 | PS00375 | |
| Domain | UDPGT | 9.13e-12 | 21 | 18 | 5 | PF00201 | |
| Domain | UDP_glucos_trans | 9.13e-12 | 21 | 18 | 5 | IPR002213 | |
| Domain | RIBOSOMAL_L44E | 8.77e-07 | 2 | 18 | 2 | PS01172 | |
| Domain | - | 8.77e-07 | 2 | 18 | 2 | 3.10.450.80 | |
| Domain | Ribosomal_L44e | 8.77e-07 | 2 | 18 | 2 | PD002841 | |
| Domain | Ribosomal_L44e | 8.77e-07 | 2 | 18 | 2 | IPR000552 | |
| Domain | Ribosomal_L44 | 8.77e-07 | 2 | 18 | 2 | PF00935 | |
| Domain | zf-C2H2_6 | 9.31e-06 | 314 | 18 | 5 | PF13912 | |
| Domain | Ribosomal_zn-bd | 3.15e-05 | 9 | 18 | 2 | IPR011332 | |
| Domain | KRAB | 3.28e-04 | 358 | 18 | 4 | PS50805 | |
| Domain | KRAB | 3.28e-04 | 358 | 18 | 4 | PF01352 | |
| Domain | - | 3.61e-04 | 679 | 18 | 5 | 3.30.160.60 | |
| Domain | KRAB | 3.68e-04 | 369 | 18 | 4 | SM00349 | |
| Domain | KRAB | 3.72e-04 | 370 | 18 | 4 | IPR001909 | |
| Domain | zf-C2H2 | 3.97e-04 | 693 | 18 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.00e-04 | 694 | 18 | 5 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 6.63e-04 | 775 | 18 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 6.70e-04 | 777 | 18 | 5 | PS00028 | |
| Domain | Znf_C2H2-like | 7.48e-04 | 796 | 18 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 7.87e-04 | 805 | 18 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.01e-04 | 808 | 18 | 5 | SM00355 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.40e-11 | 25 | 15 | 5 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.40e-11 | 25 | 15 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 4.21e-11 | 26 | 15 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.28e-11 | 28 | 15 | 5 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.75e-10 | 41 | 15 | 5 | M7399 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 8.26e-10 | 14 | 15 | 4 | M39328 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.48e-09 | 51 | 15 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.64e-09 | 52 | 15 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.19e-09 | 55 | 15 | 5 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.77e-09 | 64 | 15 | 5 | M9488 | |
| Pathway | WP_ESTROGEN_METABOLISM | 6.00e-09 | 22 | 15 | 4 | MM15888 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.54e-09 | 70 | 15 | 5 | M16794 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.71e-09 | 24 | 15 | 4 | MM14599 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.71e-09 | 72 | 15 | 5 | M9257 | |
| Pathway | WP_GLUCURONIDATION | 1.04e-08 | 25 | 15 | 4 | MM15820 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.68e-08 | 39 | 15 | 4 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | 7.12e-08 | 109 | 15 | 5 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 7.12e-08 | 109 | 15 | 5 | M18788 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.10e-07 | 44 | 15 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.21e-07 | 45 | 15 | 4 | MM15694 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 2.97e-07 | 145 | 15 | 5 | M45512 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.34e-06 | 220 | 15 | 5 | M10320 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.50e-06 | 29 | 15 | 3 | M45015 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.02e-06 | 107 | 15 | 4 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 6.13e-06 | 119 | 15 | 4 | MM15692 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.35e-05 | 45 | 15 | 3 | M39615 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.66e-05 | 153 | 15 | 4 | MM15844 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.35e-05 | 183 | 15 | 4 | M39588 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 6.76e-05 | 219 | 15 | 4 | MM14838 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 6.93e-05 | 12 | 15 | 2 | M39611 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.60e-04 | 18 | 15 | 2 | M39424 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.19e-04 | 21 | 15 | 2 | M39631 | |
| Pathway | BIOCARTA_P53HYPOXIA_PATHWAY | 2.19e-04 | 21 | 15 | 2 | M5202 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 2.88e-04 | 24 | 15 | 2 | M46445 | |
| Pathway | WP_NRF2_PATHWAY | 4.08e-04 | 141 | 15 | 3 | M39454 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 4.83e-04 | 31 | 15 | 2 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 5.15e-04 | 32 | 15 | 2 | M39567 | |
| Pathway | KEGG_RIBOSOME | 3.84e-03 | 88 | 15 | 2 | M189 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 4.08e-03 | 314 | 15 | 3 | M39428 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION | 4.37e-03 | 94 | 15 | 2 | M29556 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC | 4.55e-03 | 96 | 15 | 2 | MM15705 | |
| Pathway | REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY | 5.12e-03 | 102 | 15 | 2 | M29813 | |
| Pathway | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | 6.25e-03 | 113 | 15 | 2 | M567 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 6.46e-03 | 115 | 15 | 2 | MM15640 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 6.57e-03 | 116 | 15 | 2 | M27921 | |
| Pathway | REACTOME_SELENOAMINO_ACID_METABOLISM | 6.79e-03 | 118 | 15 | 2 | M27170 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 7.02e-03 | 120 | 15 | 2 | M27686 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 7.36e-03 | 123 | 15 | 2 | MM15415 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 9.06e-03 | 137 | 15 | 2 | M145 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 1.18e-02 | 157 | 15 | 2 | M4669 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_STARVATION | 1.18e-02 | 157 | 15 | 2 | M41835 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 1.40e-02 | 172 | 15 | 2 | M27876 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 1.53e-02 | 180 | 15 | 2 | MM15324 | |
| Pathway | REACTOME_RRNA_PROCESSING | 1.95e-02 | 205 | 15 | 2 | M27685 | |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 2.19e-02 | 218 | 15 | 2 | M2780 | |
| Pubmed | 1.13e-15 | 8 | 18 | 5 | 17179145 | ||
| Pubmed | 1.13e-15 | 8 | 18 | 5 | 20610558 | ||
| Pubmed | 2.54e-15 | 9 | 18 | 5 | 22511988 | ||
| Pubmed | 5.09e-15 | 10 | 18 | 5 | 23642732 | ||
| Pubmed | 5.09e-15 | 10 | 18 | 5 | 11465080 | ||
| Pubmed | 5.09e-15 | 10 | 18 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 5.09e-15 | 10 | 18 | 5 | 22558097 | |
| Pubmed | 1.60e-14 | 12 | 18 | 5 | 19419973 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.60e-14 | 12 | 18 | 5 | 20308471 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.60e-14 | 12 | 18 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.59e-14 | 13 | 18 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.59e-14 | 13 | 18 | 5 | 25246029 | |
| Pubmed | 4.04e-14 | 14 | 18 | 5 | 21646302 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.04e-14 | 14 | 18 | 5 | 14672974 | |
| Pubmed | 4.04e-14 | 14 | 18 | 5 | 9295054 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.04e-14 | 14 | 18 | 5 | 10836148 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 8.80e-14 | 16 | 18 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.25e-13 | 17 | 18 | 5 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.34e-13 | 19 | 18 | 5 | 23281178 | |
| Pubmed | 7.53e-13 | 6 | 18 | 4 | 20297805 | ||
| Pubmed | 7.53e-13 | 6 | 18 | 4 | 32527940 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 8.54e-13 | 24 | 18 | 5 | 24625756 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.76e-12 | 7 | 18 | 4 | 8467709 | |
| Pubmed | 1.76e-12 | 7 | 18 | 4 | 8464825 | ||
| Pubmed | 1.76e-12 | 7 | 18 | 4 | 27514509 | ||
| Pubmed | 3.51e-12 | 8 | 18 | 4 | 18052087 | ||
| Pubmed | 1.65e-11 | 11 | 18 | 4 | 18695635 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 8.33e-11 | 57 | 18 | 5 | 21886157 | |
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 1.16e-10 | 3 | 18 | 3 | 20007669 | |
| Pubmed | 1.16e-10 | 3 | 18 | 3 | 12847094 | ||
| Pubmed | 1.16e-10 | 3 | 18 | 3 | 29519853 | ||
| Pubmed | 1.53e-10 | 18 | 18 | 4 | 20056724 | ||
| Pubmed | 1.77e-10 | 66 | 18 | 5 | 19898482 | ||
| Pubmed | 4.65e-10 | 4 | 18 | 3 | 17558305 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 4.65e-10 | 4 | 18 | 3 | 2108603 | |
| Pubmed | 1.16e-09 | 5 | 18 | 3 | 20565459 | ||
| Pubmed | 1.16e-09 | 5 | 18 | 3 | 15057901 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 2.33e-09 | 6 | 18 | 3 | 19204906 | |
| Pubmed | 6.51e-09 | 8 | 18 | 3 | 15319294 | ||
| Pubmed | 9.76e-09 | 9 | 18 | 3 | 1339448 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 9.76e-09 | 9 | 18 | 3 | 20732626 | |
| Pubmed | 3.73e-08 | 190 | 18 | 5 | 24816252 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 6.30e-08 | 211 | 18 | 5 | 24097068 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 11677206 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 22031623 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 9647757 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 17529886 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 2.53e-07 | 2 | 18 | 2 | 10497143 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 25899702 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 18568343 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 20089735 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 11901093 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 2.53e-07 | 2 | 18 | 2 | 17603215 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 15709193 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 12944498 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 25547628 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 22901212 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 19225446 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 23721685 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 15247627 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 19244109 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 19712005 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 19996319 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 23789755 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 36571650 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 12623074 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 3542712 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 26247833 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 16397224 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 19364970 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 17406868 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 7.59e-07 | 3 | 18 | 2 | 16969497 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 12732365 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 7.59e-07 | 3 | 18 | 2 | 24453052 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 20860988 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 16636344 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 24255116 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 23700788 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 1898728 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 8276413 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 1634050 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 18946804 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 9271343 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 20147615 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 20628391 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 17965524 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 8280139 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 15855726 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 17479406 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 17072959 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2.53e-06 | 5 | 18 | 2 | 18597651 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 18556656 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 3.23e-06 | 203 | 18 | 4 | 16916647 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 4.60e-06 | 1451 | 18 | 7 | 30550785 | |
| Pubmed | 7.07e-06 | 8 | 18 | 2 | 22579593 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 7.07e-06 | 8 | 18 | 2 | 12695355 | |
| Pubmed | 7.49e-06 | 251 | 18 | 4 | 28077445 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 1.66e-05 | 12 | 18 | 2 | 19349540 | |
| Pubmed | 1.66e-05 | 12 | 18 | 2 | 18161889 | ||
| Interaction | UGT1A9 interactions | 1.70e-07 | 13 | 18 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 1.71e-07 | 57 | 18 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 2.26e-06 | 3 | 18 | 2 | int:UGT1A8 | |
| Interaction | UGT1A10 interactions | 3.21e-06 | 33 | 18 | 3 | int:UGT1A10 | |
| Interaction | MAGEB2 interactions | 2.23e-04 | 349 | 18 | 4 | int:MAGEB2 | |
| Interaction | PYHIN1 interactions | 2.46e-04 | 358 | 18 | 4 | int:PYHIN1 | |
| Cytoband | 2q37 | 8.52e-13 | 31 | 18 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.25e-08 | 226 | 18 | 5 | chr2q37 | |
| Cytoband | 19p12 | 5.70e-04 | 90 | 18 | 2 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.04e-03 | 122 | 18 | 2 | chr19p12 | |
| GeneFamily | UDP glucuronosyltransferases | 5.39e-11 | 32 | 16 | 5 | 363 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.95e-04 | 718 | 16 | 5 | 28 | |
| GeneFamily | L ribosomal proteins | 9.13e-04 | 51 | 16 | 2 | 729 | |
| Coexpression | NFE2L2.V2 | 4.92e-07 | 469 | 18 | 6 | M2870 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 3.29e-06 | 154 | 18 | 4 | MM1313 | |
| Coexpression | LIU_TOPBP1_TARGETS | 4.03e-05 | 14 | 18 | 2 | M2382 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | 4.65e-05 | 615 | 18 | 5 | MM3641 | |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 1.86e-04 | 165 | 18 | 3 | M43617 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_2HR_UP | 1.92e-04 | 30 | 18 | 2 | M15196 | |
| Coexpression | KYNG_DNA_DAMAGE_DN | 2.49e-04 | 182 | 18 | 3 | M11350 | |
| Coexpression | WU_CELL_MIGRATION | 2.53e-04 | 183 | 18 | 3 | M2001 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 3.19e-04 | 198 | 18 | 3 | M7605 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 3.23e-04 | 199 | 18 | 3 | M7607 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_DN | 3.59e-04 | 41 | 18 | 2 | MM490 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_DN | 3.77e-04 | 42 | 18 | 2 | M8155 | |
| Coexpression | CORONEL_RFX7_DIRECT_TARGETS_UP | 4.14e-04 | 44 | 18 | 2 | M42500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.87e-05 | 62 | 18 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.19e-05 | 74 | 18 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_1000 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 163 | 18 | 3 | db46baa7c37427e7e9be6e91f3b0026e6f6ea995 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 173 | 18 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 173 | 18 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 4.37e-05 | 173 | 18 | 3 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 173 | 18 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.45e-05 | 174 | 18 | 3 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-05 | 183 | 18 | 3 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-05 | 183 | 18 | 3 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.25e-05 | 184 | 18 | 3 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 188 | 18 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 189 | 18 | 3 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 189 | 18 | 3 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 189 | 18 | 3 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 5.77e-05 | 190 | 18 | 3 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-05 | 192 | 18 | 3 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-05 | 192 | 18 | 3 | d7faa993f68e530ad55185505384ae155d36c222 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.33e-05 | 196 | 18 | 3 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.52e-05 | 198 | 18 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 198 | 18 | 3 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 199 | 18 | 3 | 1b74f6fbf2628f335ba5eb49b679d2f72068bbbe | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 199 | 18 | 3 | a660f7373fca03929234cbd936735f97883fb689 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 6.62e-05 | 199 | 18 | 3 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_Tem|Multiple_Sclerosis / Disease, condition lineage and cell class | 6.62e-05 | 199 | 18 | 3 | 79145d931a250c69a643936fea147e2bd50b4d6d | |
| ToppCell | Sigmoid-T_cell-Th1|T_cell / Region, Cell class and subclass | 6.72e-05 | 200 | 18 | 3 | bc9433a8ec3a6f10816730a32b821c63d78e6e87 | |
| ToppCell | (12)_Th1|World / shred on Cell_type and subtype | 6.92e-05 | 202 | 18 | 3 | 83a9267b1a40749fba5e812901d374278f15c969 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.90e-04 | 104 | 18 | 2 | 57d2a707aacaa90f92895b87f4ecf87b7451d667 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Tubulolobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.36e-04 | 107 | 18 | 2 | a749d56a0a2fe719f8e76bea15be85d6f7770b12 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Tubulolobular_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.36e-04 | 107 | 18 | 2 | e5c1ce2b31e3e5b7acd930b7903e7cd1fb4d285c | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.10e-03 | 123 | 18 | 2 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | RV-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.36e-03 | 137 | 18 | 2 | 97f090732bc73db1cff050b1d6380b5ecc9a95e5 | |
| ToppCell | RV-05._Cytoplasmic_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.55e-03 | 146 | 18 | 2 | 25c61342a8acc3a7681365a7710598e07e72990e | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.59e-03 | 148 | 18 | 2 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.59e-03 | 148 | 18 | 2 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.63e-03 | 150 | 18 | 2 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-03 | 158 | 18 | 2 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | Basal_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-03 | 158 | 18 | 2 | dd069a822e9698e6dddc155d9a5b52383f7879d5 | |
| ToppCell | (04)_Pre-ciliated-(2)_48hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.83e-03 | 159 | 18 | 2 | e1f36b237e314ef6a18224eb8f3b97a612c39506 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-03 | 160 | 18 | 2 | 445cef1f2f3279672620664792d4eec54df71bdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-03 | 161 | 18 | 2 | 2a721b6228045adb2dfbcd4990d371f961dc5dc2 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.88e-03 | 161 | 18 | 2 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.88e-03 | 161 | 18 | 2 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | Influenza_Severe-NK_CD56bright|World / Disease group and Cell class | 1.88e-03 | 161 | 18 | 2 | de802ff96b52d28550a7854fc915f813c76ea271 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.90e-03 | 162 | 18 | 2 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.90e-03 | 162 | 18 | 2 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-03 | 162 | 18 | 2 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-03 | 162 | 18 | 2 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Influenza_Severe-NK_CD56bright|Influenza_Severe / Disease group and Cell class | 1.92e-03 | 163 | 18 | 2 | 7748d5709e8cf6673f5a8370108309f76cd830f4 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.94e-03 | 164 | 18 | 2 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.97e-03 | 165 | 18 | 2 | 34f0394356b96e31b87fb8c2fd323cf7a3f077e3 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 165 | 18 | 2 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.02e-03 | 167 | 18 | 2 | 69de7d7fc69d699eab03dfea84fdb54263aa5a47 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.06e-03 | 169 | 18 | 2 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-03 | 171 | 18 | 2 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.11e-03 | 171 | 18 | 2 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-03 | 171 | 18 | 2 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-03 | 171 | 18 | 2 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-03 | 171 | 18 | 2 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.14e-03 | 172 | 18 | 2 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 172 | 18 | 2 | bd01b39a5699824ab14827cc9dc98e547d65b160 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.14e-03 | 172 | 18 | 2 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-03 | 172 | 18 | 2 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.14e-03 | 172 | 18 | 2 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-03 | 174 | 18 | 2 | 911eac6f6ec1e5e85348a7fe774243498388a810 | |
| ToppCell | droplet|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-03 | 174 | 18 | 2 | 62553b0979e6d8f0b5fb95015f4d7adb116d6269 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.18e-03 | 174 | 18 | 2 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-03 | 174 | 18 | 2 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.21e-03 | 175 | 18 | 2 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_TEM|IIF / Disease, Lineage and Cell Type | 2.21e-03 | 175 | 18 | 2 | 0e7cde3bd638ab85abe915d40c432123f92af4fc | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-03 | 177 | 18 | 2 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-03 | 177 | 18 | 2 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-03 | 177 | 18 | 2 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-03 | 177 | 18 | 2 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-03 | 178 | 18 | 2 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-03 | 178 | 18 | 2 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-03 | 178 | 18 | 2 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-03 | 178 | 18 | 2 | e2363810d77b6b245394a666eb51bacd345c43f7 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-03 | 178 | 18 | 2 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-03 | 178 | 18 | 2 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-03 | 178 | 18 | 2 | c30d3390fc4a7856f50ba8ff6694c0333165ddde | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-03 | 178 | 18 | 2 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-03 | 178 | 18 | 2 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-03 | 178 | 18 | 2 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-03 | 179 | 18 | 2 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-03 | 179 | 18 | 2 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-03 | 179 | 18 | 2 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | droplet|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-03 | 179 | 18 | 2 | 1c29ecd294c140d73417bf1c11fe8bd3edd24eb7 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-03 | 180 | 18 | 2 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 2.33e-03 | 180 | 18 | 2 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-03 | 180 | 18 | 2 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-03 | 180 | 18 | 2 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-03 | 180 | 18 | 2 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.36e-03 | 181 | 18 | 2 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-03 | 181 | 18 | 2 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| Drug | AC1MRQNQ | 2.11e-14 | 9 | 18 | 5 | CID003522271 | |
| Drug | Chebi:32663 | 2.11e-14 | 9 | 18 | 5 | CID005460873 | |
| Drug | 3-iodophenol | 2.11e-14 | 9 | 18 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 2.11e-14 | 9 | 18 | 5 | CID000186631 | |
| Drug | DHPASiU | 2.11e-14 | 9 | 18 | 5 | CID000197602 | |
| Drug | 4-nitrophenyl)imidazole | 7.75e-14 | 11 | 18 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 7.75e-14 | 11 | 18 | 5 | CID006442661 | |
| Drug | N-OH-DABZ | 1.33e-13 | 12 | 18 | 5 | CID000051366 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.33e-13 | 12 | 18 | 5 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 1.33e-13 | 12 | 18 | 5 | CID000160090 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.33e-13 | 12 | 18 | 5 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.33e-13 | 12 | 18 | 5 | CID000037247 | |
| Drug | tritanol | 2.16e-13 | 13 | 18 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.16e-13 | 13 | 18 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.16e-13 | 13 | 18 | 5 | CID000000411 | |
| Drug | propranolol glucuronide | 3.35e-13 | 14 | 18 | 5 | CID000119515 | |
| Drug | PCB-61 | 3.35e-13 | 14 | 18 | 5 | CID000036401 | |
| Drug | sulforaphane nitrile | 5.02e-13 | 15 | 18 | 5 | CID000543743 | |
| Drug | afloqualone | 5.02e-13 | 15 | 18 | 5 | CID000002040 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 5.02e-13 | 15 | 18 | 5 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 5.02e-13 | 15 | 18 | 5 | CID000010752 | |
| Drug | naphthyl sulphate | 5.02e-13 | 15 | 18 | 5 | CID000114775 | |
| Drug | 1'-hydroxyestragole | 7.31e-13 | 16 | 18 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 7.31e-13 | 16 | 18 | 5 | CID005497144 | |
| Drug | quercetin-3,4'-diglucoside | 7.31e-13 | 16 | 18 | 5 | CID005320835 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.03e-12 | 17 | 18 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.03e-12 | 17 | 18 | 5 | CID000037766 | |
| Drug | anthrarobin | 1.37e-12 | 5 | 18 | 4 | ctd:C032186 | |
| Drug | naringenin chalcone | 1.37e-12 | 5 | 18 | 4 | ctd:C027329 | |
| Drug | ApApG | 1.43e-12 | 18 | 18 | 5 | CID003081975 | |
| Drug | C1 11-32 | 1.43e-12 | 18 | 18 | 5 | CID000443077 | |
| Drug | C11131 | 1.43e-12 | 18 | 18 | 5 | CID000443076 | |
| Drug | SureCN12722713 | 1.43e-12 | 18 | 18 | 5 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.43e-12 | 18 | 18 | 5 | CID000036614 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.43e-12 | 18 | 18 | 5 | CID000152226 | |
| Drug | Br 2 | 1.43e-12 | 18 | 18 | 5 | CID003060900 | |
| Drug | almokalant | 1.94e-12 | 19 | 18 | 5 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.94e-12 | 19 | 18 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.94e-12 | 19 | 18 | 5 | CID000091433 | |
| Drug | AC1L1OBF | 2.59e-12 | 20 | 18 | 5 | CID000032736 | |
| Drug | tectochrysin | 2.59e-12 | 20 | 18 | 5 | CID005281954 | |
| Drug | 4'-hydroxydiclofenac | 2.59e-12 | 20 | 18 | 5 | CID000116545 | |
| Drug | estriol-16-glucuronide | 3.40e-12 | 21 | 18 | 5 | CID000122281 | |
| Drug | Benzamidoxime hydrochloride | 3.40e-12 | 21 | 18 | 5 | CID000069186 | |
| Drug | dulcin | 3.40e-12 | 21 | 18 | 5 | CID000009013 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 4.10e-12 | 6 | 18 | 4 | ctd:C543211 | |
| Drug | alloin | 4.10e-12 | 6 | 18 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 4.10e-12 | 6 | 18 | 4 | ctd:C107497 | |
| Drug | amonafide | 4.39e-12 | 22 | 18 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 4.39e-12 | 22 | 18 | 5 | CID000053167 | |
| Drug | estradiol-3-glucuronide | 5.61e-12 | 23 | 18 | 5 | CID000066651 | |
| Drug | phenanthridine | 5.61e-12 | 23 | 18 | 5 | CID000009189 | |
| Drug | amidoxime | 5.61e-12 | 23 | 18 | 5 | CID000465967 | |
| Drug | AS-3201 | 7.08e-12 | 24 | 18 | 5 | CID000153948 | |
| Drug | N-acetylbenzidine | 8.85e-12 | 25 | 18 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 8.85e-12 | 25 | 18 | 5 | CID000006796 | |
| Drug | 5-MOP | 8.85e-12 | 25 | 18 | 5 | CID000002355 | |
| Drug | N-phenylmaleimide | 8.85e-12 | 25 | 18 | 5 | CID000013662 | |
| Drug | Hymecromone | 8.85e-12 | 25 | 18 | 5 | ctd:D006923 | |
| Drug | AzMC | 8.85e-12 | 25 | 18 | 5 | CID000064986 | |
| Drug | 2',4'-dihydroxychalcone | 9.55e-12 | 7 | 18 | 4 | ctd:C059354 | |
| Drug | Scopoletin | 1.34e-11 | 27 | 18 | 5 | ctd:D012603 | |
| Drug | licochalcone A | 1.34e-11 | 27 | 18 | 5 | ctd:C070840 | |
| Drug | DiMeIQx | 1.34e-11 | 27 | 18 | 5 | CID000104739 | |
| Drug | diflunisal | 1.34e-11 | 27 | 18 | 5 | CID000003059 | |
| Drug | H-Ni | 1.63e-11 | 28 | 18 | 5 | CID000445665 | |
| Drug | CARMINE | 1.63e-11 | 28 | 18 | 5 | CID000014749 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.63e-11 | 28 | 18 | 5 | CID000081261 | |
| Drug | erucin | 1.63e-11 | 28 | 18 | 5 | CID000078160 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.91e-11 | 8 | 18 | 4 | ctd:C034890 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.97e-11 | 29 | 18 | 5 | CID005375667 | |
| Drug | AC1L1JAL | 1.97e-11 | 29 | 18 | 5 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.97e-11 | 29 | 18 | 5 | CID000125641 | |
| Drug | iberin | 1.97e-11 | 29 | 18 | 5 | CID000010455 | |
| Drug | trans-3'-hydroxycotinine | 1.97e-11 | 29 | 18 | 5 | CID000000414 | |
| Drug | paricalcitol | 2.37e-11 | 30 | 18 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 2.37e-11 | 30 | 18 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 2.37e-11 | 30 | 18 | 5 | CID000107770 | |
| Drug | tolcapone | 2.37e-11 | 30 | 18 | 5 | CID004659569 | |
| Drug | 4-ethylphenol | 2.82e-11 | 31 | 18 | 5 | CID000031242 | |
| Drug | PCB 156 | 2.82e-11 | 31 | 18 | 5 | CID000038019 | |
| Drug | 4'-HPPH | 2.82e-11 | 31 | 18 | 5 | CID000017732 | |
| Drug | Muracein C | 3.34e-11 | 32 | 18 | 5 | CID003086323 | |
| Drug | NNAL | 3.34e-11 | 32 | 18 | 5 | CID000104856 | |
| Drug | indole-2-carboxylic acid | 3.34e-11 | 32 | 18 | 5 | CID000072899 | |
| Drug | 6-methylsalicylic acid | 3.94e-11 | 33 | 18 | 5 | CID000011279 | |
| Drug | norbuprenorphine | 3.94e-11 | 33 | 18 | 5 | CID000114976 | |
| Drug | geniposide | 3.94e-11 | 33 | 18 | 5 | CID000107848 | |
| Drug | BP-3,6-quinol | 3.94e-11 | 33 | 18 | 5 | CID000119292 | |
| Drug | R(-)-Denopamine | 3.94e-11 | 33 | 18 | 5 | CID000003818 | |
| Drug | AC1Q6OQG | 3.94e-11 | 33 | 18 | 5 | CID000009686 | |
| Drug | estragole | 4.61e-11 | 34 | 18 | 5 | CID000008815 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.38e-11 | 35 | 18 | 5 | CID010436171 | |
| Drug | AC1NOWCJ | 5.38e-11 | 35 | 18 | 5 | CID005120112 | |
| Drug | estrone-3-glucuronide | 5.38e-11 | 35 | 18 | 5 | CID000115255 | |
| Drug | 2,6-dihydroxyanthraquinone | 5.72e-11 | 10 | 18 | 4 | ctd:C034889 | |
| Drug | glucoraphanin | 6.25e-11 | 36 | 18 | 5 | CID000656556 | |
| Drug | AC1L9DGV | 6.25e-11 | 36 | 18 | 5 | CID000417381 | |
| Drug | anisole | 6.25e-11 | 36 | 18 | 5 | CID000007519 | |
| Drug | bevirimat | 6.25e-11 | 36 | 18 | 5 | CID000457928 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.61e-17 | 5 | 15 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.61e-17 | 5 | 15 | 5 | EFO_0801853 | |
| Disease | X-21339 measurement | 3.38e-16 | 7 | 15 | 5 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0021260 | |
| Disease | Succinimide measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0022118 | |
| Disease | X-24849 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0800909 | |
| Disease | cholelithiasis, bilirubin measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0004570, EFO_0004799 | |
| Disease | X-11530 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0021249 | |
| Disease | X-11522 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0800696 | |
| Disease | X-10458 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0800692 | |
| Disease | serum N-desmethylclozapine measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0802740 | |
| Disease | X-16946 measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 9.02e-16 | 8 | 15 | 5 | EFO_0801034 | |
| Disease | X-11442 measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0021235 | |
| Disease | X-11880 measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0800698 | |
| Disease | circulating cell free DNA measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0004739 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.03e-15 | 9 | 15 | 5 | EFO_0801036 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.03e-15 | 9 | 15 | 5 | EFO_0004570, GO_0009410 | |
| Disease | X-21448 measurement | 4.06e-15 | 10 | 15 | 5 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.06e-15 | 10 | 15 | 5 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 4.06e-15 | 10 | 15 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | X-23974 measurement | 4.06e-15 | 10 | 15 | 5 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0800972 | |
| Disease | aldosterone measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0010219 | |
| Disease | X-21796 measurement | 7.43e-15 | 11 | 15 | 5 | EFO_0800825 | |
| Disease | biliverdin measurement | 1.27e-14 | 12 | 15 | 5 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.27e-14 | 12 | 15 | 5 | EFO_0800079 | |
| Disease | pregnenetriol disulfate measurement | 2.07e-14 | 13 | 15 | 5 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 2.07e-14 | 13 | 15 | 5 | EFO_0802007 | |
| Disease | X-21441 measurement | 9.94e-14 | 17 | 15 | 5 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.94e-14 | 17 | 15 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 1.38e-13 | 18 | 15 | 5 | EFO_0801382 | |
| Disease | 5-hydroxyindole sulfate measurement | 2.16e-13 | 5 | 15 | 4 | EFO_0800085 | |
| Disease | tissue factor measurement | 3.26e-13 | 21 | 15 | 5 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.57e-12 | 28 | 15 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 1.90e-12 | 29 | 15 | 5 | EFO_0010551 | |
| Disease | response to dolutegravir | 2.28e-12 | 30 | 15 | 5 | EFO_0600017 | |
| Disease | vitamin D deficiency | 6.96e-12 | 37 | 15 | 5 | EFO_0003762 | |
| Disease | vitamin D measurement, COVID-19 | 3.04e-11 | 49 | 15 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 7.27e-11 | 58 | 15 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.06e-10 | 3 | 15 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 1.06e-10 | 3 | 15 | 3 | EFO_0800043 | |
| Disease | thyroxine measurement | 4.58e-10 | 83 | 15 | 5 | EFO_0005130 | |
| Disease | hormone measurement | 4.87e-10 | 84 | 15 | 5 | EFO_0004730 | |
| Disease | cholelithiasis | 6.17e-10 | 88 | 15 | 5 | EFO_0004799 | |
| Disease | gallstones | 1.74e-09 | 108 | 15 | 5 | EFO_0004210 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.12e-09 | 6 | 15 | 3 | EFO_0800566 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.27e-09 | 147 | 15 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | indoleacetate measurement | 1.27e-08 | 10 | 15 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 3.03e-08 | 13 | 15 | 3 | EFO_0800898 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.38e-07 | 914 | 15 | 7 | EFO_0004532 | |
| Disease | vitamin D measurement | 5.08e-07 | 336 | 15 | 5 | EFO_0004631 | |
| Disease | free androgen index | 8.62e-07 | 374 | 15 | 5 | EFO_0007005 | |
| Disease | bilirubin measurement | 1.96e-06 | 442 | 15 | 5 | EFO_0004570 | |
| Disease | metabolite measurement | 6.21e-06 | 560 | 15 | 5 | EFO_0004725 | |
| Disease | urate measurement, bone density | 1.01e-05 | 619 | 15 | 5 | EFO_0003923, EFO_0004531 | |
| Disease | late-onset Alzheimers disease | 1.18e-05 | 292 | 15 | 4 | EFO_1001870 | |
| Disease | apolipoprotein B measurement | 1.41e-05 | 663 | 15 | 5 | EFO_0004615 | |
| Disease | dodecanedioate measurement | 1.59e-05 | 12 | 15 | 2 | EFO_0021054 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.99e-05 | 713 | 15 | 5 | EFO_0005689 | |
| Disease | serum metabolite measurement | 7.66e-05 | 945 | 15 | 5 | EFO_0005653 | |
| Disease | urinary bladder carcinoma | 2.57e-04 | 47 | 15 | 2 | MONDO_0004986 | |
| Disease | testosterone measurement | 3.12e-04 | 1275 | 15 | 5 | EFO_0004908 | |
| Disease | temporal horn of lateral ventricle volume measurement | 6.04e-04 | 72 | 15 | 2 | EFO_0010333 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGYKKRSLKCLSHDG | 926 | Q9UHI8 | |
| LVALCKKRLKRHGKY | 141 | Q14526 | |
| KKRLKRHGKYCHLRG | 146 | Q14526 | |
| KRCKHFELGGDKKRK | 86 | Q969Q0 | |
| KSKNGAYGREKKRCK | 1081 | P46100 | |
| CGKLHKKGRKLCVYA | 201 | Q96PZ2 | |
| YKKKQCRPSKGRKRG | 246 | P17936 | |
| LSGCRRHYSVKKKLK | 21 | Q9UI40 | |
| KRCKHFELGGDKKRK | 86 | P83881 | |
| HKYNKCGRGFKKKSV | 281 | Q5HYK9 | |
| RHTGKKPFKCKNRGK | 166 | Q03936 | |
| YRKCLGKKGRVKKAH | 511 | Q9HAW8 | |
| HKGVKRGGSKRKYRK | 21 | P09430 | |
| RHTGKKLLKCKEYVR | 166 | P0DKX0 | |
| HKRVQRGEKSCKYKK | 471 | O95780 | |
| YRKCLGKKGRVKKAH | 511 | O60656 | |
| YGYRKCLGKKGRVKK | 511 | P19224 | |
| YRKCLGKKGRVKKAH | 511 | Q9HAW7 | |
| YRKCLGKKGRVKKAH | 511 | Q9HAW9 |